NuVasive Inc

$68.49 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About NuVasive Inc

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

Stock Analysis

last close $67.51
1-mo return 7.6%
3-mo return 19.9%
avg daily vol. 663.99T
52-week high 69.28
52-week low 43.11
market cap. $3.3B
forward pe 30.1
annual div. -
roe -4.1%
ltg forecast 20.3%
dividend yield -
annual rev. $1.1B
inst own. -
baraka

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist